Home / ATG3 Knockout Cell Lines

ATG3 Knockout Cell Lines

Gene: ATG3

Official Full Name: autophagy related 3provided by HGNC

Gene Summary: This gene encodes a ubiquitin-like-conjugating enzyme and is a component of ubiquitination-like systems involved in autophagy, the process of degradation, turnover and recycling of cytoplasmic constituents in eukaryotic cells. This protein is known to play a role in regulation of autophagy during cell death. A pseudogene of this gene is located on chromosome 20. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jul 2013]

Get A Quote
Products Background

Products

Catalog Number Product Name Species Gene Passage ratio Mycoplasma testing Price
KO19607 ATG3 Knockout cell line (HeLa) Human ATG3 1:3~1:6 Negative Online Inquiry
KO19608 ATG3 Knockout cell line (HCT 116) Human ATG3 1:2~1:4 Negative Online Inquiry
KO19609 ATG3 Knockout cell line (HEK293) Human ATG3 1:3~1:6 Negative Online Inquiry
KO19610 ATG3 Knockout cell line (A549) Human ATG3 1:3~1:4 Negative Online Inquiry

Background

ATG3 Gene Knockout Cell Lines are genetically engineered cellular models designed to specifically remove the expression of the autophagy-related gene ATG3. This gene plays a crucial role in the autophagy process, particularly in the conjugation of ATG12-ATG5, which is essential for the formation of autophagosomes. These knockout cell lines provide researchers with the ability to study the physiological and molecular consequences of ATG3 deficiency, thereby illuminating the role of autophagy in cellular homeostasis, stress responses, and various pathological conditions.

By successfully silencing the ATG3 gene, these cell lines serve as powerful tools for elucidating the mechanisms of autophagy and its implications in disease states such as cancer, neurodegenerative disorders, and infections. The ability to manipulate autophagic processes in controlled environments allows for in-depth investigations into how dysregulation of this pathway contributes to disease progression, making these cell lines highly relevant in both fundamental research and drug discovery contexts.

One of the standout advantages of ATG3 Gene Knockout Cell Lines is their specificity, which minimizes off-target effects and provides clearer insights compared to traditional pharmacological inhibitors or RNA interference approaches. Available in various cell types, these lines can be easily integrated into existing experimental frameworks, thereby allowing researchers to tailor their studies to specific conditions or cellular environments.

For clinicians and researchers pursuing advancements in autophagy-related therapies, these knockout cell lines represent a valuable asset in developing targeted interventions. Additionally, their use can facilitate the identification of novel biomarkers or therapeutic targets, significantly contributing to the field of regenerative medicine and cancer therapy.

Our company, with a strong commitment to innovation in biological products, ensures that all ATG3 Gene Knockout Cell Lines meet high-quality standards, supported by extensive validation and characterization. This expertise empowers scientists in their quest to uncover the complexities of cellular mechanisms and translates their findings into practical applications.

Please note that all services are for research use only. Not intended for any clinical use.

Get a free quote

If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.

0

There is no product in your cart.